Cannabinoids as a Treatment for Insomnia in Major Depression

NCT05041647 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Insomnia
Depressive Disorder, Major
Sleep Disorder
Depression
Insomnia Chronic

Interventions

DRUG: 25:1 CBD/THC
DRUG: 5:1 CBD/THC
OTHER: Placebo

Sponsor

St. Joseph's Healthcare Hamilton

Collaborators

McMaster University